» Articles » PMID: 11683963

Allergen-induced Murine Upper Airway Inflammation: Local and Systemic Changes in Murine Experimental Allergic Rhinitis

Overview
Journal Immunology
Date 2001 Oct 31
PMID 11683963
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The role of inflammatory effector cells in the pathogenesis of airway allergy has been the subject of much investigation. However, whether systemic factors are involved in the development of local responses in both upper and lower airways has not been fully clarified. The present study was performed to investigate aspects of the pathogenesis of isolated allergic rhinitis in a murine model sensitized to ovalbumin (OVA). Both upper- and lower-airway physiological responsiveness and inflammatory changes were assessed, as well as bone marrow progenitor responses, by culture and immunohistological methods. Significant nasal symptoms and hyper-responsiveness appeared after intranasal OVA challenge (P < 0.0001 and P < 0.01, respectively), accompanied with significant nasal mucosal changes in CD4+ cells (P < 0.001), interleukin (IL)-4+ cells (P < 0.01), IL-5+ cells (P < 0.01), basophilic cells (P < 0.02) and eosinophils (P < 0.001), in the complete absence of hyper-responsiveness or inflammatory changes in the lower airway. In the bone marrow, there were significant increases in CD34+ cells, as well as in eosinophils and basophilic cells. In the presence in vitro of mouse recombinant IL-5, IL-3 or granulocyte-macrophage colony-stimulating factor (GM-CSF), the level of bone marrow eosinophil/basophil (Eo/Baso) colony-forming cells increased significantly in the OVA-sensitized group. We conclude that, in this murine model of allergic rhinitis, haemopoietic progenitors are upregulated, which is consistent with the involvement of bone marrow in the pathogenesis of nasal mucosal inflammation. Both local and systemic events, initiated in response to allergen provocation, may be required for the pathogenesis of allergic rhinitis. Understanding these events and their regulation could provide new therapeutic targets for rhinitis and asthma.

Citing Articles

A Novel Approach for Investigating Upper Airway Hyperresponsiveness Using Micro-CT in Eosinophilic Upper Airway Inflammation such as Allergic Rhinitis Model.

Bui D, Kanda A, Kobayashi Y, Sakata Y, Kono Y, Kamakura Y Biomolecules. 2019; 9(7).

PMID: 31252670 PMC: 6681309. DOI: 10.3390/biom9070252.


Essential Contribution of CD4+ T Cells to Antigen-Induced Nasal Hyperresponsiveness in Experimental Allergic Rhinitis.

Nishimura T, Kaminuma O, Saeki M, Kitamura N, Matsuoka K, Yonekawa H PLoS One. 2016; 11(1):e0146686.

PMID: 26752722 PMC: 4709066. DOI: 10.1371/journal.pone.0146686.


Ethyl pyruvate attenuates murine allergic rhinitis partly by decreasing high mobility group box 1 release.

Chen S, Wang Y, Gong G, Chen J, Niu Y, Kong W Exp Biol Med (Maywood). 2015; 240(11):1490-9.

PMID: 25681468 PMC: 4935307. DOI: 10.1177/1535370214566563.


Establishment and characterization of an experimental mouse model of allergic rhinitis.

Ko M, Huang S, Kang H Eur Arch Otorhinolaryngol. 2014; 272(5):1149-55.

PMID: 25027946 DOI: 10.1007/s00405-014-3176-2.


Influence of chronic sinusitis and nasal polyp on the lower airway of subjects without lower airway diseases.

Lee S, Yoon S, Song W, Lee S, Kang H, Kim S Allergy Asthma Immunol Res. 2014; 6(4):310-5.

PMID: 24991454 PMC: 4077957. DOI: 10.4168/aair.2014.6.4.310.


References
1.
Wood L, Inman M, Watson R, Foley R, Denburg J, OByrne P . Changes in bone marrow inflammatory cell progenitors after inhaled allergen in asthmatic subjects. Am J Respir Crit Care Med. 1998; 157(1):99-105. DOI: 10.1164/ajrccm.157.1.9704125. View

2.
Elsas M, Joseph D, Elsas P, Vargaftig B . Rapid increase in bone-marrow eosinophil production and responses to eosinopoietic interleukins triggered by intranasal allergen challenge. Am J Respir Cell Mol Biol. 1997; 17(4):404-13. DOI: 10.1165/ajrcmb.17.4.2691. View

3.
Asakura K, Saito H, Watanabe M, Ogasawara H, Matsui T, KATAURA A . Effects of anti-IL-5 monoclonal antibody on the murine model of nasal allergy. Int Arch Allergy Immunol. 1998; 116(1):49-52. DOI: 10.1159/000023924. View

4.
Dahl R, Mygind N . Mechanisms of airflow limitation in the nose and lungs. Clin Exp Allergy. 1998; 28 Suppl 2:17-25. View

5.
Mygind N, Dahl R, Nielsen L . Effect of nasal inflammation and of intranasal anti-inflammatory treatment on bronchial asthma. Respir Med. 1998; 92(3):547-9. DOI: 10.1016/s0954-6111(98)90306-7. View